An O18-Labeling Assisted LC-MS Method for Accurate Quantitation of Unprocessed C-terminal Lysine in Therapeutic Monoclonal Antibodies.

Shunhai Wang,Anita P. Liu,Ning Li

DOI: https://doi.org/10.1021/jasms.0c00149

IF: 3.262

2020-06-09

Journal of the American Society for Mass Spectrometry

Abstract:Unprocessed C-terminal lysine (C-term Lys) is one of the most common causes for the formation of basic variants in therapeutic mAbs. Although the C-term Lys variants are routinely quantified by LC-MS-based peptide mapping method using the relative MS responses from both C-terminal peptides (with and without Lys), this approach often leads to overestimation of Lys-containing peptide due to the intrinsic difference in ionization efficiency. Herein, we report an O18-labeling assisted LC-MS method, which takes advantage of the carboxypeptidase B-catalyzed Lys removal and O18-labeling, to achieve improved accuracy of C-term Lys quantitation. The fidelity of this method was first demonstrated using synthetic peptide mixture standards that mimic a wide range of C-term Lys levels. Finally, the newly developed method was applied in a case study, where C-term Lys variants in mAb samples manufactured from different processes were accurately quantified and compared. This new method provides a valuable solution for studies where accurate C-term Lys levels are needed to assist decision-making and root-cause investigation.

Chemistry